GtoPdb Ligand ID: 6890

Synonyms: IGE25 | olizumab | R03DX05 | RG-3648 | rhumab-E25 | Xolair®
omalizumab is an approved drug (FDA (2003), EMA (2005))
Compound class: Antibody
Comment: Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
Peptide sequence analysis reveals that omalizumab is clone e25 in patent US5994511 [3].
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: omalizumab

Compound class Antibody
Approved drug? Yes (FDA (2003), EMA (2005))
International Nonproprietary Names
INN number INN
8039 omalizumab
IGE25 | olizumab | R03DX05 | RG-3648 | rhumab-E25 | Xolair®
Database Links
Specialist databases
IMGT/mAb-DB 77
Other databases
GtoPdb PubChem SID 178103472
PubChem SID 178103472
Search PubMed clinical trials omalizumab
Search PubMed titles omalizumab
Search PubMed titles/abstracts omalizumab
Wikipedia Omalizumab